HOME › Top Market Reports › 3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022

3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: November 2017
Report Code: BT 4414

The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 570.4 Million in 2016 growing at a CAGR of 20.3% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

The objectives of this study are as follows:

To define, describe, segment, and forecast the global market on the basis of product application, end user, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and market-specific trends)
To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of competitive landscape for market leaders
To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
To profile key players and comprehensively analyze their market shares and core competencies
To track and analyze competitive developments such as agreements, partnerships, and collaborations; acquisitions; product launches and approvals; expansions; and R&D activities in the global market

Research Methodology

The study estimates the 3D cell culture market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the global market. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the 3D cell culture market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

3D Cell Culture Market

To know about the assumptions considered for the study, download the pdf brochure

The 3D cell culture market is highly competitive with the presence of various players. Some of the major players operating in the market are Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US), Nano3D Biosciences (US), and QGel (Switzerland).

Target Audience for this Report:

Manufacturers of 3D cell culture products
Pharmaceutical and biotechnology companies
Research and development companies
Research institutes
Research and consulting firms
Venture capitalists

Scope of the Report

This report categorizes the 3D cell culture market into following segments and subsegments:

By Product

Scaffold-based 3D Cell Culture
- Hydrogels/ECM Analogs
- Solid Scaffolds
- Micropatterned Surfaces
Scaffold-free Cell Culture
- Low-adhesion Microplates
- Hanging Drop Plates
- 3D Bioreactors
- 3D Petri Dishes
Microfluidics-based 3D Cell Culture
Magnetic levitation & 3D Bioprinting

By Application

Cancer and Stem Cell Research
Drug Discovery and Toxicology
Tissue Engineering & Regenerative Medicine

By End User

Pharmaceutical & Biotechnology Companies
Research Institutes

By Region

North America
- US
- Canada
Europe
- Germany
- UK
- France
- RoE
Asia Pacific
Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for this report.

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Data
    2.2 Secondary Data
           2.2.1 Secondary Sources
    2.3 Primary Data
           2.3.1 Primary Sources
           2.3.2 Industry Insights
    2.4 Market Size Estimation
    2.5 Market Breakdown and Data Triangulation
    2.6 Market Share Estimation
    2.7 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 29)
    4.1 3D Cell Culture Market Overview
    4.2 Global Market, By Product
    4.3 Europe: Scaffold-Free Market, By Type
    4.4 Global Market, By Application
    4.5 Global Market, By End User
    4.6 Global Market: Geographic Snapshot

5 Market Overview (Page No. - 33)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Focus on Developing Alternatives to Animal Testing
                    5.2.1.2 Availability of Funding for Research
                    5.2.1.3 Technological Advancements & New Product Launches
                    5.2.1.4 Growing Awareness
           5.2.2 Restraints
                    5.2.2.1 Lack of Infrastructure
           5.2.3 Opportunities
                    5.2.3.1 Emergence of Microfluidics-Based 3D Cell Culture
                    5.2.3.2 Regenerative Medicine, an Alternative to Organ Transplantation
           5.2.4 Challenges
                    5.2.4.1 Lack of Consistency in 3D Cell Culture Products

6 3D Cell Culture Market, By Product (Page No. - 38)
    6.1 Introduction
    6.2 Scaffold-Based 3D Cell Culture
           6.2.1 Hydrogels/ECM Analogs
           6.2.2 Solid Scaffolds
           6.2.3 Micropatterned Surfaces
    6.3 Scaffold-Free 3D Cell Culture
           6.3.1 Low-Adhesion Microplates
           6.3.2 Hanging Drop Plates
           6.3.3 3D Bioreactors
           6.3.4 3D Petri Dishes
    6.4 Microfluidics-Based 3D Cell Culture
    6.5 Magnetic Levitation & 3D Bioprinting

7 3D Cell Culture Market, By Application (Page No. - 57)
    7.1 Introduction
    7.2 Cancer and Stem Cell Research
    7.3 Drug Discovery and Toxicology Testing
    7.4 Tissue Engineering and Regenerative Medicine

8 3D Cell Culture Market, By End User (Page No. - 64)
    8.1 Introduction
    8.2 Pharmaceutical & Biotechnology Companies
    8.3 Research Institutes

9 3D Cell Culture Market, By Region (Page No. - 69)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 UK
           9.3.3 France
           9.3.4 Rest of Europe (RoE)
    9.4 Asia Pacific (APAC)
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 99)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends
             10.3.1 Agreements, Partnerships, and Collaborations
             10.3.2 Product Launches and Approvals
             10.3.3 Expansions
             10.3.4 Acquisitions

11 Company Profiles (Page No. - 106)
(Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments,)*
     11.1 Thermo Fisher Scientific
     11.2 Corning
     11.3 Merck
     11.4 Lonza
     11.5 Reprocell
     11.6 3D Biotek
     11.7 Emulate
     11.8 Global Cell Solutions
     11.9 Hamilton
     11.10 Insphero
     11.11 Kuraray
     11.12 Mimetas
     11.13 Nano3D Biosciences
     11.14 Synthecon
     11.15 Qgel

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 133)
     12.1 Insights Form Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details

List of Tables (111 Tables)

Table 1 Key Product Launches (2014-2017)
Table 2 Recent Conferences, Workshops, and Forums for 3D Cell Culture Market
Table 3 3D Cell Culture Market, By Product, 2015-2022, USD Million
Table 4 Scaffold-Based 3D Cell Culture Market, By Type, 2015-2022, USD Million
Table 5 Scaffold-Based Market, By Region, 2015-2022, USD Million
Table 6 North America: Scaffold-Based Market, By Country, 2015-2022 (USD Million)
Table 7 Europe: Scaffold-Based Market, By Country, 2015-2022 (USD Million)
Table 8 Hydrogels/ECM Analogs Market, By Region, 2015-2020, USD Million
Table 9 North America: Hydrogels/ECM Analogs Market, By Country, 2015-2022 (USD Million)
Table 10 Europe: Hydrogels/ECM Analogs Market, By Country, 2015-2022 (USD Million)
Table 11 Solid Scaffolds Market, By Region, 2015-2020, USD Million
Table 12 North America: Solid Scaffolds Market, By Country, 2015-2022 (USD Million)
Table 13 Europe: Solid Scaffolds Market, By Country, 2015-2022 (USD Million)
Table 14 Micropatterned Surfaces Market, By Region, 2015-2020, USD Million
Table 15 North America: Micropatterned Surfaces Market, By Country, 2015-2022 (USD Million)
Table 16 Europe: Micropatterned Surfaces Market, By Country, 2015-2022 (USD Million)
Table 17 Scaffold-Free 3D Cell Culture Market, By Type, 2015-2020, USD Million
Table 18 Low-Adhesion Microplates Market, By Region, 2015-2020, USD Million
Table 19 North America: Low-Adhesion Microplates Market, By Country, 2015-2022 (USD Million)
Table 20 Europe: Low-Adhesion Microplates Market, By Country, 2015-2022 (USD Million)
Table 21 Hanging Drop Plates Market, By Region, 2015-2020, USD Million
Table 22 North America: Hanging Drop Plates Market, By Country, 2015-2022 (USD Million)
Table 23 Europe: Hanging Drop Plates Market, By Country, 2015-2022 (USD Million)
Table 24 3D Bioreactors Market, By Region, 2015-2020, USD Million
Table 25 North America: 3D Bioreactors Market, By Country, 2015-2022 (USD Million)
Table 26 Europe: 3D Bioreactors Market, By Country, 2015-2022 (USD Million)
Table 27 3D Petri Dishes Market, By Region, 2015-2020, USD Million
Table 28 North America: 3D Petri Dishes Market, By Country, 2015-2022 (USD Million)
Table 29 Europe: 3D Petri Dishes Market, By Country, 2015-2022 (USD Million)
Table 30 Microfluidics-Based 3D Cell Culture Market, By Region, 2015-2020, USD Million
Table 31 North America: Microfluidics-Based 3D Cell Culture Market, By Country, 2015-2022 (USD Million)
Table 32 Europe: Microfluidics-Based 3D Cell Culture Market, By Country, 2015-2022 (USD Million)
Table 33 Magnetic Levitation & 3D Bioprinting Market, By Region, 2015-2020, USD Million
Table 34 North America: Magnetic Levitation & 3D Bioprinting Market, By Country, 2015-2022 (USD Million)
Table 35 Europe: Magnetic Levitation & 3D Bioprinting Market, By Country, 2015-2022 (USD Million)
Table 36 3D Cell Culture Market, By Application, 2015–2022 (USD Million)
Table 37 Global Market for Cancer and Stem Cell Research, By Region, 2015–2022 (USD Million)
Table 38 North America: Market for Cancer and Stem Cell Research, By Country, 2015–2022 (USD Million)
Table 39 Europe: Market for Cancer and Stem Cell Research, By Country, 2015–2022 (USD Million)
Table 40 3D Cell Culture Market for Drug Discovery and Toxicity Testing, By Region, 2015–2022 (USD Million)
Table 41 North America: Market for Drug Discovery and Toxicity Testing, By Country, 2015–2022 (USD Million)
Table 42 Europe: Market for Drug Discovery and Toxicity Testing, By Country, 2015–2022 (USD Million)
Table 43 Market for Tissue Engineering and Regenerative Medicine, By Region, 2015–2022 (USD Million)
Table 44 North America: Market for Tissue Engineering and Regenerative Medicine, By Country, 2015–2022 (USD Million)
Table 45 Europe: Market for Tissue Engineering and Regenerative Medicine, By Country, 2015–2022 (USD Million)
Table 46 3D Cell Culture Market, By End User, 2015–2022 (USD Million)
Table 47 Market for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 48 North America: Market for Pharmaceutical & Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 49 Europe: Market for Pharmaceutical & Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 50 3D Cell Culture Market for Research Institutes, By Region, 2015–2022 (USD Million)
Table 51 North America: Market for Research Institutes, By Country, 2015–2022 (USD Million)
Table 52 Europe: Market for Research Institutes, By Country, 2015–2022 (USD Million)
Table 53 3D Cell Culture Market, By Region, 2015–2022 (USD Million)
Table 54 North America: 3D Cell Culture Market, By Country, 2015–2022 (USD Million)
Table 55 North America: Market, By Product, 2015–2022 (USD Million)
Table 56 North America: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 57 North America: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 58 North America: Market, By Application, 2015–2022 (USD Million)
Table 59 North America: Market, By End User, 2015–2022 (USD Million)
Table 60 US: 3D Cell Culture Market, By Product, 2015–2022 (USD Million)
Table 61 US: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 62 US: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 63 US: Market, By Application, 2015–2022 (USD Million)
Table 64 US: Market, By End User, 2015–2022 (USD Million)
Table 65 Canada: 3D Cell Culture Market, By Product, 2015–2022 (USD Million)
Table 66 Canada: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 67 Canada: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 68 Canada: Market, By Application, 2015–2022 (USD Million)
Table 69 Canada: Market, By End User, 2015–2022 (USD Million)
Table 70 Europe: 3D Cell Culture Market, By Country, 2015–2022 (USD Million)
Table 71 Europe: Market, By Product, 2015–2022 (USD Million)
Table 72 Europe: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 73 Europe: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 74 Europe: Market, By Application, 2015–2022 (USD Million)
Table 75 Europe: Market, By End User, 2015–2022 (USD Million)
Table 76 Germany: 3D Cell Culture Market, By Product, 2015–2022 (USD Million)
Table 77 Germany: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 78 Germany: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 79 Germany: Market, By Application, 2015–2022 (USD Million)
Table 80 Germany: Market, By End User, 2015–2022 (USD Million)
Table 81 UK: 3D Cell Culture Market, By Product, 2015–2022 (USD Million)
Table 82 UK: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 83 UK: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 84 UK: Market, By Application, 2015–2022 (USD Million)
Table 85 UK: Market, By End User, 2015–2022 (USD Million)
Table 86 France: 3D Cell Culture Market, By Product, 2015–2022 (USD Million)
Table 87 France: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 88 France: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 89 France: Market, By Application, 2015–2022 (USD Million)
Table 90 France: Market, By End User, 2015–2022 (USD Million)
Table 91 RoE: 3D Cell Culture Market, By Product, 2015–2022 (USD Million)
Table 92 RoE: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 93 RoE: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 94 RoE: Market, By Application, 2015–2022 (USD Million)
Table 95 RoE: Market, By End User, 2015–2022 (USD Million)
Table 96 APAC: 3D Cell Culture Market, By Product, 2015–2022 (USD Million)
Table 97 APAC: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 98 APAC: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 99 APAC: Market, By Application, 2015–2022 (USD Million)
Table 100 APAC: Market, By End User, 2015–2022 (USD Million)
Table 101 RoW: 3D Cell Culture Market, By Product, 2015–2022 (USD Million)
Table 102 RoW: Scaffold-Based Market, By Type, 2015–2022 (USD Million)
Table 103 RoW: Scaffold-Free Market, By Type, 2015–2022 (USD Million)
Table 104 RoW : Market, By Application, 2015–2022 (USD Million)
Table 105 RoW: Market, By End User, 2015–2022 (USD Million)
Table 106 Recent Agreements, Partnerships, and Collaborations
Table 107 Recent Product Launch and Approvals
Table 108 Recent Expansions
Table 109 Recent Acquisitions
Table 110 Exchange Rates (Utilized for Conversion of Euro to USD)
Table 111 Exchange Rates (Utilized for Conversion of Chf to USD)

List of Figures (35 Figures)

Figure 1 Research Design
Figure 2 Break Down of Primary Interviews: By Company, Designation, and Region
Figure 3 Market Estimation: Bottom-Up Approach
Figure 4 Global Market Size of 3D Cel Culture Market : Top-Down Approach
Figure 5 Data Triangulation Methododlogy
Figure 6 Scaffold-Based 3D Cell Culture Products to Offer Significant Growth Opportunities
Figure 7 Hydrogels/ECM Analogs to Witness Highest Growth During the Forecast Period
Figure 8 Cancer & Stem Cell Research Segment to Dominate the 3D Cell Culture Applications Market in 2017
Figure 9 Pharmaceutical & Biotechnology Companies to Dominate the 3D Cell Culture End-User Market
Figure 10 Europe to Witness High Growth During the Forecast Period
Figure 11 Focus on Developing Alternatives to Animal Testing to Drive the Growth of the Market
Figure 12 Scaffold-Based 3D Cell Culture to Account for the Largest Market Share in 2017
Figure 13 Europe: Ultra-Low Adhesion Plates to Account for the Largest Share of the Scaffold-Free 3D Cell Culture Market in 2017
Figure 14 Cancer & Stem Cell Research to Witness High Growth From 2017 to 2022
Figure 15 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Market in 2017
Figure 16 Germany to Witness Highest Growth During the Forecast Period
Figure 17 3D Cell Culture Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Scaffold-Based 3D Cell Culture to Dominate the Market During the Forecast Period
Figure 19 Hydrogels/ECM Analogs to Dominate the Market During the Forecast Period
Figure 20 Low-Adhesion Microplates to Grow at the Highest CAGR During the Forecast Period
Figure 21 Cancer and Stem Cell Research is Estimated to Be the Largest Application Segment in the Market
Figure 22 Pharmaceutical & Biotechnology Companies to Dominate the 3D Cell
Figure 23 Culture Market During the Forecast Period
Figure 24 North America Will Continue to Dominate the 3D Cell Culture Market in 2022
Figure 25 North America: Market Snapshot
Figure 26 Europe: Market Snapshot
Figure 27 Asia Pacific: Market Snapshot
Figure 28 RoW: Market Snapshot
Figure 29 Market Evolution Framework
Figure 30 Market Share Analysis, By Key Player (2016)
Figure 31 Thermo Fisher Scientific, : Company Snapshot (2016)
Figure 32 Corning: Company Snapshot (2016)
Figure 33 Merck : Company Snapshot (2016)
Figure 34 Lonza: Company Snapshot (2016)
Figure 35 Kuraray: Company Overview (2016)

The global 3D cell culture market is projected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the market.

The report segments the global market into by type of product, application, end user, and region.

Based on product, the market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and 3D bioprinting. The scaffold-based 3D cell culture products segment is expected to account for the largest market share in 2017, and is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the ability of scaffold-based products to mimic in vivo conditions, thus driving their adoption among end users.

By type, the scaffold-based 3D cell culture market is segmented into hydrogels/ECM analogs, solid scaffolds, and micropatterned surfaces. The hydrogels/ECM segment analogs are expected to account for the largest share of the scaffold-based market owing to their wide acceptance among researchers.

The global market, by applications, is segmented into cancer and stem cell research, drug discovery and toxicology testing, and tissue engineering & regenerative medicine. The cancer and stem cell research segment is estimated to account for the largest market share in 2017. Growth of this application segment is attributed to increasing incidence of cancer and significant funding initiatives for cancer research from government as well as private organizations.

Based on end users, the 3D cell culture market is segmented into pharmaceutical & biotechnology companies and research institutes. In 2017, pharmaceutical and biotechnology companies are expected to form the largest end-user segment. The presence of a large number of pharmaceutical and biotechnology companies, increasing R&D spending in these companies, and growing focus on alternative testing models instead of animal techniques are the key drivers for this end-user segment.

3D Cell Culture Market

The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW). The dominance of the North American market is attributed to factors such as increase in incidence of cancer, presence of well-established pharmaceutical and biotechnology industry, and availability of technologically advanced products.

While the laboratory informatics market represents significant growth opportunities, market growth may be hindered due to lack of infrastructure for 3D cell culture research. The 3D cell culture market is highly competitive with the presence of several big and small players. Prominent players in this market include Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US), Nano3D Biosciences (US), and QGel (Switzerland).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services